Skip to content
healthcare.dev

Mesalamine

NDC 0591-2245, Mesalamine, tablet, delayed release, from Actavis Pharma, Inc..

Product NDC
0591-2245
Status
Listed
Labeler
Actavis Pharma, Inc.
Dosage form
TABLET, DELAYED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203817
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0591-2245 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MESALAMINE1.2 g/1

Pharmacologic classes

Aminosalicylate [EPC]; Aminosalicylic Acids [CS]

Package NDCNDC-11Package
0591-2245-2200591224522120 TABLET, DELAYED RELEASE in 1 BOTTLE (0591-2245-22)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ba1e3bd4-fbe0-46a5-961e-167ccb09672c
  • NADAC price for package 00591224522

    GET /v1/drugs/nadac/00591224522

Use it

Look up 0591-2245 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0591-2245 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0591-2245. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.